Eric Sullivan
CIK 1601797 · Chief Financial Officer · last filed 2023-06-01
Eric Sullivan is a Chief Financial Officer who has filed 31 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing, for TCRR, was dated Jun 1, 2023. Across all open-market trades the lifetime net is −$3.0M, making them a net seller over the disclosed history. 29 SEC filings were submitted jointly with bluebird bio, Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BLUE price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
53 STATE ST
BOSTON, MA 02109
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TCR2 THERAPEUTICS INC. (TCRR) Delisted | Chief Financial Officer | — | $1.48 | — | $0 | 3 | 2023-06-01 |
| bluebird bio, Inc. (BLUE) Delisted | Principal Accounting Officer | 299 | $4.97 | $1.5K | -$3.03M | 28 | 2017-08-07 |
Recent Filings
31 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-01 | TCR2 THERAPEUTICS INC. (TCRR) Delisted | Disp (D) | — | $0 | EDGAR |
| 2022-12-19 | TCR2 THERAPEUTICS INC. (TCRR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-27 | TCR2 THERAPEUTICS INC. (TCRR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-08-07 | bluebird bio, Inc. (BLUE) Delisted | Mixed | — | -$47.7K | EDGAR |
| 2017-07-07 | bluebird bio, Inc. (BLUE) Delisted | Mixed | −733 | -$277.5K | EDGAR |
| 2017-06-30 | bluebird bio, Inc. (BLUE) Delisted | Mixed | −59 | -$493.1K | EDGAR |
| 2017-05-09 | bluebird bio, Inc. (BLUE) Delisted | Grant (A) | +300 | $0 | EDGAR |
| 2017-03-20 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −411 | -$40.7K | EDGAR |
| 2017-03-02 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −285 | -$25.4K | EDGAR |
| 2017-02-03 | bluebird bio, Inc. (BLUE) Delisted | Grant (A) | +1,750 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.